BMRN ridiculous Morningstar analyst target price!
Morningstar weekly highlights set Biomarin Pharmaceuticals with an amazing $119 fair price value (50% above current price).
- Rating: 4 stars
- Uncertainty rating: Medium
- Moat: Narrow